We suggest that one of the mechanisms by which GSZC granules improve airway inflammation is intervention in the MUC5AC/EGFR signaling pathway, and inhibition of mucus hypersecretion in the airways of rats suffering from asthma. The gene discussed is EGFR; the disease is asthma.